One patient in the intervention arm missed 2 doses within a 7 day period, requiring a pharmacist follow up call per study protocol

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

Our previous studies indicated that targeting the cyclin cdk pathway is a novel therapeutic strategy for RTs and that a pan cdk inhibitor, flavopiridol, inhibits RT growth